Success Stories: NAILG Guided Associate Research Scientist in Synthetic Organic Chemistry From NIW to EB-1A Approval
Client’s Testimonial:
“Thank you all for your sincere efforts and unwavering support throughout this journey. It wouldn’t have been possible without your dedication. It has truly been a pleasure working with each of you.”
On October 20th, 2023, and May 12th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for an Associate Research Scientist in the Field of Synthetic Organic Chemistry (Approval Notice).
General Field: Synthetic Organic Chemistry
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: India
State of Residence at the Time of Filing: Indiana
Approval Notice Date: : October 20th, 2023 (NIW) and May 12th, 2025 (EB1A)
Processing Time: 25 days (NIW) (Premium Processing Requested), and 1 year, 2 months, 26 days (EB1A)
Case Summary:
Our client is a recognized authority in synthetic organic chemistry, specializing in the development of small-molecule ligands with applications in drug discovery and pharmaceutical development. His research has significantly contributed to the advancement of anti-diabetic and anti-cancer compounds, as well as the design of FAP-targeted ligands. His work stands at the forefront of pharmaceutical innovation, directly impacting the vitality of the pharmaceutical industry and improving human health.
Over the years, he has made original contributions of major significance in synthetic chemistry, with research that includes:
❖ Advancement of Dye-sensitized Solar Cells (DSSCs) for more efficient energy generation
❖ Development of modified constituents to generate anti-diabetic and anti-cancer compounds
❖ The introduction of novel constituents to build biologically significant compounds
❖ Design of FAP-targeted ligands with potential therapeutic applications
His academic output is a testament to his leadership in the field:● 13 peer-reviewed scientific articles, including 4 first-authored, 4 abstracts, and 1 preprint ● 6 patent applications for innovative chemical compounds and methodologies ● Publications cited in at least 27 countries and 207 citations, solidifying his place as a leading contributor to synthetic organic chemistry. ● At least 40 peer reviews further establish his standing as a respected authority within the scientific community.
One expert remarked in their recommendation:“[Client] is working in an area of great importance, as drug discovery and development are foundational to the vitality of the pharmaceutical industry and, more importantly, to human wellbeing. On a personal note, [client] is one of the hardest-working and reliable scientists I have personally observed; it was my great fortune to have collaborated closely with him for our time together at Purdue. Considering the merits of his research in conjunction with his broader contributions to the field, [client] has clearly established himself at the forefront of the field of synthetic organic chemistry.”
North America Immigration Law Group (NAILG) worked closely with him throughout his NIW and EB-1A petitions, ensuring his exceptional achievements were clearly demonstrated. After initially receiving an NIW approval, NAILG helped transition our client to the EB-1A petition process, where our team highlighted not only his academic excellence but also the national relevance of his contributions to pharmaceutical innovation and human health. With careful planning and strategic submission, NAILG ensured the petition was strong and compelling, leading to EB-1A approval without delays.